FDA flags concerns at Akorn's Amityville plant

Akorn Inc said on Thursday the U.S. Food and Drug Administration pointed out certain concerns at its manufacturing plant in Amityville, New York, that included lack of records on the maintenance and cleaning of equipment.

from Reuters: Health News https://ift.tt/2BWQveO
via IFTTT